|
J Biol Chem, Vol. 273, Issue 29, 18122-18129, July 17, 1998
Aerolysin Induces G-protein Activation and Ca2+
Release from Intracellular Stores in Human Granulocytes*
Karl-Heinz
Krause ,
Marc
Fivaz§,
Antoinette
Monod , and
F.
Gisou
van der Goot§¶
From the Infectious Diseases Division, University
Hospital, 1211 Geneva 14, Switzerland and the § Department
of Biochemistry, University of Geneva, 30 quai E. Ansermet,
1211 Geneva 4, Switzerland
 |
ABSTRACT |
Aerolysin is a pore-forming toxin that plays a
key role in the pathogenesis of Aeromonas hydrophila
infections. In this study, we have analyzed the effect of aerolysin on
human granulocytes (HL-60 cells). Proaerolysin could bind to these
cells, was processed into active aerolysin, and led to membrane
depolarization, indicating that granulocytes are potential targets for
this toxin. Fura-2 measurements were used to analyze the effect of
aerolysin on cytosolic [Ca2+] homeostasis. As expected
for a pore-forming toxin, aerolysin addition led to Ca2+
influx across the plasma membrane. In addition, the toxin triggered Ca2+ release from agonist and thapsigargin-sensitive
intracellular Ca2+ stores. This Ca2+ release
was independent of the aerolysin-induced Ca2+ influx and
occurred in two kinetically distinct phases: an initial rapid and
transient phase and a second, more sustained, phase. The first, but not
the second phase was sensitive to pertussis toxin. Activation of
pertussis toxin-sensitive G-proteins appeared to be a consequence of
pore formation, rather than receptor activation through
aerolysin-binding, as it: (i) was not observed with a binding
competent, insertion-incompetent aerolysin mutant, (ii) had a marked
lag time, and (iii) was also observed in response to other bacterial
pore-forming toxins (staphylococcal -toxin, streptolysin O) which
are thought to bind to different receptors. G-protein activation
through pore-forming toxins stimulated cellular functions, as evidenced
by pertussis toxin-sensitive chemotaxis. Our results demonstrate that
granulocytes are potential target cells for aerolysin and that in these
cells, Ca2+ signaling in response to a pore-forming toxin
involves G-protein-dependent cell activation and
Ca2+ release from intracellular stores.
 |
INTRODUCTION |
Aerolysin is a pore-forming toxin secreted by the human pathogen
Aeromonas hydrophila and has been shown to be an important virulence factor produced by this bacterium (1-5). A. hydrophila has been implicated in a variety of diseases ranging
from gastroenteritis to deep wound infection and septicemia. The
importance of aerolysin in the pathogenicity of the bacterium is best
illustrated by the fact that immunization against the toxin leads to
protection toward the bacterium.
The toxin is secreted by A. hydrophila as a dimeric inactive
precursor (6, 7) which can be activated by proteolytic cleavage of a
C-terminal peptide (8, 9). The toxin as well as the protoxin interact
with the target cell by binding to specific receptors (10-14). At
present all identified receptors were found to be
GPI1 anchored. However,
different receptors were found on different cells types and a given
cell type was found to have more then one receptor. For example,
aerolysin was shown to bind to Thy-1 as well as other GPI-anchored
proteins on T-lymphocytes, to Thy-1 and contactin in mouse brain (11,
13), to VSG from Trypanosomes (13), to an 47-kDa receptor on rat
erythrocytes (12) and to mainly an 80-kDa receptor on baby hamster
kidney cells (14). Binding was shown to be determined both by the
protein moiety and the olisaccharides of the anchor (13). Binding to
the cell surface presumably leads to a local increase in toxin
concentration thereby enabling aerolysin to polymerize into a
heptameric complex that inserts into the membrane and forms a
water-filled channel (6, 15-18). Cells such as erythrocytes, that are
unable to cope with such membrane damage, undergo osmotic lysis. In
nucleated mammalian cells, the mechanisms leading to cell death appear
to be more complex. We have indeed recently found that subnanomolar doses of aerolysin do not induce lysis of baby hamster kidney cells
(14). Permeabilization but not disruption of the plasma membrane was
observed followed by selective vacuolation of the endoplasmic reticulum
(14). Only several hours later could a loss of plasma membrane
integrity be observed. It is at present not clear whether the pores
formed by the toxin at the plasma membrane are the sole cause of the
observed effects. These findings, however, do suggest that aerolysin
may trigger a cascade of events from the plasma membrane.
In this study, we have analyzed the effects of aerolysin on human
granulocytes. We show that, in addition to formation of pores in the
plasma membrane, aerolysin triggered, through activation of a pertussis
toxin-sensitive G-protein, chemotaxis, and release of Ca2+
from intracellular stores.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Cell culture media were obtained from Life
Technologies, Inc. (Paisley, Scotland), U73122 from Calbiochem (La
Jolla, CA), and DiSC3(5), PBFI, and fura-2/AM from
Molecular Probes (Eugene, OR). All other chemicals were purchased from
Sigma or Fluka. The "Ca2+-free medium" contained: 143 mM NaCl, 6 mM KCl, 1 mM
MgSO4, 5.6 mM glucose (0.1%), 20 mM HEPES pH 7.4, and 0.1 mM EGTA. The
"Ca2+ medium" consisted of Ca2+-free medium
supplemented with 1 mM CaCl2.
Culture of HL-60 Cells--
HL-60 cells were cultured in RPMI
1640 medium supplemented with 10% heat-inactivated fetal calf serum,
penicillin (50 units/ml), streptomycin (50 µg/ml), and
L-glutamine (2 mM) at 37 °C in a humidified
atmosphere of 5% CO2, 95% air. Granulocytic
differentiation was initiated by addition of dimethyl sulfoxide
(Me2SO) (final concentration 1.3% for 3 days, then 0.65%
for 1 or 2 days).
Proaerolysin Purification--
Wild type and variant
proaerolysins were purified as described previously (19).
Concentrations were determined by measuring the optical density (O.D.)
at 280 nm, considering that a 1 mg/ml sample has an O.D. of 2.5 (20).
Proaerolysin was labeled with I using IODO-GEN reagent
(Pierce) according to the manufacturers recommendations.
125I-Proaerolysin was separated from the free iodine by gel
filtration on a PD10-G25 column (Pharmacia, Sweden) equilibrated with
phosphate-buffered saline. We consistently obtained a specific activity
of about 2 × 106 cpm/µg of proaerolysin.
125I-Proaerolysin ran as a single band on an SDS gel.
Aerolysin was obtained by treating proaerolysin with trypsin at a
protein to enzyme ratio of 1/20 (mol:mol) for 10 min at room
temperature. After which a 10-fold excess of trypsin inhibitor was
added.
Proaerolysin Binding Experiments--
HL-60 granulocytes at a
concentration of 2 × 106 cells/ml in Ca2+
medium were incubated with 125I-proaerolysin for 25 min at
4 °C, spun down in a table top cell centrifuge for 8 min at 1600 rpm, resuspended in the same volume of buffer. The last washing step
was performed twice. In competition experiments,
125I-proaerolysin and the unlabeled wild type or mutant
toxin were added to the cells simultaneously. For SDS-PAGE analysis,
cells were briefly sonicated with a tip sonicator in sample buffer. SDS-PAGE was performed as described by Laemmli (21).
Membrane Potential Measurements--
HL-60 granulocytes were
washed once and resuspended in buffer containing 20 mM
HEPES pH 7.4, 143 mM NaCl, 5 mM KCl, 1 mM MgSO4, 1 mM CaCl2,
5.6 mM glucose, to a final density of 3 × 106 cells/ml. DiS-C3(5) (100 µM
in Me2SO) was added to a final concentration of 200 nM. Membrane incorporation of the dye was monitored
spectrofluorimetrically using a Photon Technology International
fluorometer equipped with a thermostated cuvette holder (excitation 625 nm; emission 670 nm; 10 nm slits). After reaching a steady state
fluorescence, the toxin was added. Maximal depolarization was obtained
at the end of each experiment by adding pre-mixed valinomycin and
nigericin to final concentrations of 2 and 5 µM,
respectively (22). Single fluorescent traces were expressed as the
ratio I(t)/Imax,
i.e. fluorescence intensity at a given time over maximal
fluorescence intensity.
Measurements of Intracellular K+
Concentration--
HL-60 granulocytes were washed once and resuspended
in loading medium, containing 20 mM HEPES pH 7.4, 5.6 mM glucose, 143 mM NaCl, 6 mM KCl,
1 mM MgSO4, 1 mM CaCl2,
0.5% bovine serum albumin, and 0.25 mM sulfinpyrazone, to
a final density of 20 × 106 cells/ml (22). Cells were
incubated with the cell-permeant form of the K+-binding
benzofuran isophtalate dye PBFI-AM (stock solution in Me2SO
in presence of pluronic acid F-127, final concentrations of 5 µM PBFI and 0.02% F-127) for 30 min at 37 °C,
followed by 30 min at room temperature, washed once and resuspended in
the same buffer, in the absence of bovine serum albumin, to a final density of 2 × 106 cells/ml. Fluorescence
measurements were performed using a Photon Technology International
fluorometer. The excitation and emission wavelengths were 343 and 460 nm, respectively (37 °C). Variations of intracellular K+
contents were expressed as a fraction of PBFI maximal intensity.
Measurements of Ethidium Homodimer-1 and Ethidium Bromide Cell
Entry--
HL-60 granulocytes were washed once and resuspended in 20 mM HEPES pH 7.4, 5.6 mM glucose, 143 mM NaCl, 6 mM KCl, 1 mM
MgSO4, 1 mM CaCl2, to a final
density of 20 × 106 cells/ml. Ethidium homodimer-1
(stock solution 2 mM in Me2SO/water, 1:4) or
ethidium bromide (stock solution 10 mg/ml in water) were added to a
final concentration of 6 nM and 100 µM,
respectively. Aerolysin-induced ethidium homodimer-1 or ethidium
bromide entry was monitored by measuring the increase of fluorescence
intensity at 600 nm, upon excitation at 500 or 340 nm, respectively.
Single fluorescent traces were normalized to maximal fluorescence
obtained by the addition of 1% Triton X-100.
Measurement of Cytosolic Free Ca2+
Concentrations--
[Ca2+]c was measured with
the fluorescent Ca2+ indicator fura-2. Cells (2 × 107/ml) suspended in Ca2+ medium containing
0.1% bovine serum albumin were loaded for 45 min at 37 °C with 2 µM fura-2/AM, then diluted to 107/ml and kept
on ice. Just before use, a sample of loaded cells (2 × 106/ml) was centrifuged and resuspended in the desired
medium. Fluorescence measurements were performed on a Perkin-Elmer
fluorometer (LS3, Perkin-Elmer), thermostated at 37 °C. Excitation
and emission wavelengths were 340 and 505 nm, respectively. Calibration
was performed for each cuvette by sequential addition of 2 mM Ca2+ (for Ca2+-free medium), 1 µM ionomycin to measure Ca2+ saturated fura-2
(Fmax), followed by 24 mM EGTA, 75 mM Tris, pH 9.3, and 0.1% Triton X-100 to measure
Ca2+ free fura-2 (Fmin). A
relatively small leakage of fura-2 occurred in cells exposed to
aerolysin (see "Results"). Results are shown as relative fura-2
fluorescence, normalized with respect to the maximal fluorescence
(=100%) and minimal fluorescence (=0%) values obtained through the
calibration procedure.
Measurement of Mn2+ and Ni2+
Entry--
At an excitation wavelength of 360 nm, fura-2 fluorescence
is Ca2+ independent, the fluorescence of the probe is,
however, quenched by several divalent cations. In this study, we used
this feature of the probe to study entry of Mn2+ and
Ni2+ in response to aerolysin independently from changes in
[Ca2+]c. Cell-associated fluorescence before
addition of the respective divalent cation was defined as 100%
fluorescence. For the quantitation of the Mn2+ influx at
different times after aerolysin addition, we proceeded as described
previously (23). Briefly, the percentage of fluorescence quenching that
occurred within 1 min after Mn2+ addition was determined.
The relatively small fraction of the fluorescence quenching that was
due to the presence of extracellular fura (see below) was subtracted.
The emission wavelength was 505 nm.
Determination of Extracellular Fura-2--
To determine the
amount of extracellular fura-2, we exposed fura-2-loaded cells for
various times to aerolysin, followed by the addition of 25 µM Mn2+ and, 1 min later, 100 µM of the heavy metal chelator
diethylenetriaminepentaacetic acid. Under these conditions, the
fraction of the Mn2+-induced fluorescence quenching that is
immediately reversible after addition diethylenetriaminepentaacetic
acid is a direct measure of extracellular fura-2 (23).
Chemotaxis Assay--
For the chemotaxis assay, a Transwell®
chemotaxis chamber (6.5 mm diameter, 3 µm pore size, Corning Costar
Corp., Cambridge, MA) was used. In this system, the cell reservoir
(=upper chamber) is separated from the target chamber (=lower chamber)
by a microporous membrane. The cell reservoir contained 106
cells in 100 µl of Ca2+ buffer with 0.1% bovine serum
albumin. The target chamber contained the indicated concentration of
chemoattractant or the appropriate solvent control in 500 µl of
Ca2+ buffer with 0.1% bovine serum albumin. Chemotaxis was
allowed to occur over a period of 90 min in an CO2 (5%)
and temperature (37 °C)-controlled incubator. Cells in the target
chamber were counted. Results are expressed as cells recovered in the
target chamber (% of cells that were initially added in the cell
reservoir).
 |
RESULTS |
Binding to HL-60 Cells--
As a first step in the
characterization of the interaction of proaerolysin with myeloid cells,
we have investigated whether proaerolysin was able to bind to HL-60
promyelocytes and HL-60 granulocytes. Cells were incubated with 1 nM proaerolysin at 4 °C for 10 min, washed, sedimented,
and analyzed by SDS-PAGE followed by Western blot analysis for the
presence of the toxin. Both wild type proaerolysin as well as a double
cysteine mutant, G202C/I445C (see below), were able to bind to both
types of HL-60 cells (not shown).
To investigate whether binding of proaerolysin was specific, we have
analyzed whether radiolabeled and unlabeled proaerolysin could compete
for binding to HL-60 cells. Binding of radiolabeled proaerolysin (4 nM) to both promyelocytic and granulocytic HL-60 could be
inhibited by more than 80% by the presence of a 100-fold excess of
unlabeled toxin (0.4 µM), indicating the presence of a
limited number of binding sites. Binding of radiolabeled wild type
toxin could also be inhibited, to the same extend, by unlabeled G202C/I445C mutant toxin, indicating that both forms of the toxin bind
to the same sites.
These observations suggest that aerolysin binds to a limited number of
sites on HL-60 cells. Using a previously described proaerolysin overlay
assay (14), we could identify 4 proaerolysin-binding proteins (not
shown). Binding to these proteins could be inhibited by 70% by
treating the cells with the phosphatidylinositol-specific phospholipase
C indicating that these putative receptors were GPI anchored (not
shown). These four proteins remain to be identified. We could, however,
exclude that binding occurred via Thy-1, which was shown to be a
receptor for aerolysin on T-lymphocytes (11), since HL-60 do not
express this protein to any significant extent (24). The presence of
multiple receptors on HL-60 granulocytes is reminiscent of what was
observed in rat brain, were at least two receptors were found, Thy-1
and contactin (13), and on baby hamster kidney cells were three
putative GPI-anchored receptors were seen of, respectively, 140, 80, and 30 kDa, the 80-kDa protein being the major proaerolysin-binding
protein (14).
Aerolysin Induces Plasma Membrane Depolarization in HL-60
Granulocytes--
To investigate whether HL-60 granulocytes are
sensitive to aerolysin, we have analyzed the effect of the toxin on
membrane potential using the fluorescent probe DiSC3(5)
which has been widely used for this purpose (25). As shown in Fig.
1A, proaerolysin led to
depolarization of the granulocytes with kinetics that were dose-dependent. As suspected, a marked increase in the rate
of depolarization was observed when activating the protoxin prior to
the addition to the cells (Fig. 1B). As shown in Fig.
1C, depolarization was in part due to the efflux of
K+. As a control, we tested the hemolytically inactive
mutant of aerolysin, G202C/I445C. This mutant contains two engineered
cystein residues that form a disulfide bridge between the propeptide
and the mature toxin (20). Even after trypsin activation, this mutant is unable to lyse erythrocytes presumably because it cannot
oligomerize. Also G202C/I445C did not induce K+ efflux from
HL-60 granulocytes. Surprisingly, depolarization of HL-60 granulocytes
as well as K+ efflux followed two-step kinetics for reasons
that remain to be established. In contrast, kinetics of membrane
depolarization induced by the thiol-activated toxin streptolysin O were
monophasic (not shown).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
Aerolysin selectively permeabilizes the
plasma membrane of HL-60 granulocytes. A and B,
changes induced by proaerolysin (A) and trypsin-activated
aerolysin (B) of the fluorescence of the membrane potential
sensitive probe DiSC3(5) after uptake by HL-60
granulocytes. C, the aerolysin induced change in
intracellular K+ was followed by monitoring the changes of
PBFI fluorescence after loading the cells with this dye as described
under "Experimental Procedures." Trypsin-activated aerolysin was
added at the time indicated by an arrow. D,
aerolysin induced influx in ethidium bromide (dashed line)
and ethidium homodimer-1 (full line). Trypsin-activated
aerolysin was added at the time indicated by an arrow.
|
|
The observed K+ efflux and membrane depolarization were not
due to lysis of the cells as illustrated by the fact that most cells
still exclude ethidium homodimer-1 after 10 min (Fig. 1D). Faster kinetics of entry were observed with the smaller dye ethidium bromide indicating that a sieving mechanism was taking place. This
observation suggests that the dye enters the cells through the
aerolysin pore and not through a breach in the plasma membrane since in
the latter case no discrimination in size would be expected. We can
therefore conclude that aerolysin led to selective permeabilization of
the plasma membrane and not to cell lysis within the time frame of the
present experiments. Aerolysin was also able to induce membrane
depolarization and K+ efflux in HL-60 promyelocytes,
although the kinetics were dramatically slower then those observed for
granulocytes (not shown).
Since membrane depolarization could be observed not only when treating
the cells with aerolysin but also with proaerolysin, albeit at far
slower rate, we investigated whether HL-60 granulocytes expressed
proteases able to process the protoxin. As shown in Fig.
2, although the protoxin added to the
cells showed no sign of contamination by aerolysin (lane a),
a lower molecular weight form corresponding to aerolysin could be
observed upon interaction with the granulocytes. A higher molecular
weight band could also be observed upon incubation at 37 °C
corresponding to the aerolysin heptamer (Fig. 2). These results agree
well with our previous observations that proaerolysin can be converted
into aerolysin by proteases provided by the host cell
(14).2

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 2.
HL-60 granulocytes express proteases able to
convert proaerolysin to its active form. HL-60 granulocytes were
incubated with 50 ng/ml 125I-proaerolysin in
Ca2+ medium for 25 min at 4 °C and washed twice with
toxin free Ca2+ medium. Cells were then incubated for the
indicated times at 37 °C in a toxin-free medium. a,
proaerolysin marker; b, aerolysin marker, other lanes are
labeled according to the incubation time at 37 °C. Approximately
300,000 cells were loaded per well. Note that although the complex is
not covalent, the aerolysin heptamer is not dissociated by SDS and thus
migrates at a high molecular weight.
|
|
These observations show that proaerolysin and aerolysin are able to
bind to HL-60 cells and that the cells express proteases that can
process the protoxin to its mature form. This allows heptamerization of
the toxin and channel formation thereby leading to efflux of
intracellular potassium, presumably to concomitant sodium entry, and
membrane depolarization.
Aerolysin Induces [Ca2+]c Elevations
Which Display Complex Kinetics--
To investigate whether the
interaction of aerolysin with myeloid cells led to changes in cytosolic
free Ca2+ concentration ([Ca2+]c), we
exposed fura-2 loaded HL-60 promyelocytes and HL-60 granulocytes to
either proaerolysin or trypsin-activated aerolysin (Fig.
3). Both, the protoxin and the mature
toxin induced elevation of [Ca2+]c in a
dose-dependent manner and this in both cell types. The
kinetics of the [Ca2+]c increase were, however,
markedly faster when the mature toxin was added rather than its
precursor as previously observed for membrane depolarization (Fig. 3,
A and C versus B and D). Also, the
effects of both the pro and the mature toxin were more pronounced on
the differentiated granulocytic HL-60 cells then on the immature
promyelocytic cells. No changes in [Ca2+]c could
be observed upon addition of the hemolytically inactive G202C/I445C
mutant when added either in the pro or the mature form (Fig.
3D).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
[Ca2+]c
elevations in response to proaerolysin and trypsin-activated
aerolysin. [Ca2+]c was recorded in
fura-2-loaded HL-60 promyelocytes (A and C) and
HL-60 granulocytes (B and D) incubated in
Ca2+ buffer. At times indicated by an arrow,
cells were treated with either proaerolysin (A and
B) or trypsin-activated aerolysin (C and
D). All experiments were performed with the wild type toxin,
except for the indicated curve in D, where the cells were
treated with the trypsin-activated G202C/I445C inactive mutant.
|
|
A striking feature of the aerolysin-induced
[Ca2+]c elevations was their complex kinetics.
Rather than presenting a monophasic increase, as might be expected for
the insertion of a pore into the membrane, the kinetics were
multiphasic: an initial, relatively rapid phase of
[Ca2+]c change was followed by a more sustained
phase.
Thus, the toxin-induced Ca2+ response in myeloid cells was
dose-dependent, accelerated by preactivation of the toxin,
and depended on the state of differentiation of the cells. As the
responses were most pronounced in HL-60 granulocytes stimulated with
the mature toxin, these conditions were used to further analyze the mechanisms underlying the complex [Ca2+]c
response to aerolysin.
Aerolysin Induces Ca2+ Release from Intracellular
Stores--
To investigate the source of the aerolysin-induced
[Ca2+]c elevations, we exposed HL-60 granulocytes
to aerolysin in a Ca2+-free medium. Under these conditions
only Ca2+ release from intracellular stores can be
detected, but not Ca2+ influx across the plasma membrane.
As shown in Fig. 4A, aerolysin (100 ng/ml) was able to induce [Ca2+]c elevations
in a Ca2+-free medium, demonstrating that the toxin
triggered Ca2+ release from intracellular stores. The
observed [Ca2+]c elevations had complex kinetics.
An initial phase peaked and decayed after approximately 40-60 s. A
prolonged phase which increased toward a plateau could be observed 1-3
min after toxin addition. The binding competent, insertion-incompetent
mutant G202C/I445C did not induce Ca2+-release (Fig.
4A). However, when added in excess, the mutant was able to
preclude Ca2+ release in response to wild type aerolysin
(Fig. 4B) confirming that the two variants of the toxin have
the same acceptor sites on the cell and that they are limited in
number.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 4.
Aerolysin-dependent
Ca2+ release from intracellular stores and Ca2+
influx across the plasma membrane. [Ca2+]c
was recorded in fura-2-loaded HL-60 granulocytes incubated in
Ca2+-free buffer. However, near the end of each experiment,
1 mM Ca2+ was added as indicated. The
unlabeled arrows indicate the time at which the toxin,
mutant or wild type, was added. A, addition of wild type
aerolysin (100 ng/ml), the inactive mutant G2202C/I445C (100 ng/ml), or
buffer (control). B, addition of an excess of inactive
mutant G2202C/I445C (5 µg/ml) or buffer (no mutant) was followed by
addition of wild type aerolysin (100 ng/ml). C, addition of
wild type aerolysin (100 ng/ml) to cells that had been preincubated
with or without the phospholipase C inhibitor U73122 (2 µM, 5 min).
|
|
Many agonists induce Ca2+ release from intracellular stores
through phospholipase C (PLC)-mediated Ins(1,4,5)P3
generation and Ins(1,4,5)P3-induced Ca2+
release from intracellular stores. To test whether PLC activation is
involved in the aerolysin-induced Ca2+ release from
intracellular stores, we have used the PLC inhibitor U73122. As shown
in Fig. 4C, this compound inhibited the initial phase of the
aerolysin-induced Ca2+ release, however, neither the late
phase of the Ca2+ release, nor the Ca2+ influx
observed after Ca2+ readdition were affected.
Aerolysin Activates Pertussis Toxin-sensitive G-proteins--
For
many granulocyte agonists, Ca2+ release from intracellular
stores is due to a G-protein-mediated activation of phospholipase C. In
contrast to what is observed on many other cellular systems, agonist-PLC coupling in leukocytes is generally mediated by pertussis toxin-sensitive G-proteins (26). We therefore investigated the effect
of pertussis toxin pretreatment on aerolysin-induced Ca2+
release in the HL-60 granulocytes. As shown in Fig.
5, pertussis toxin pretreatment inhibited
the initial, rapid phase of aerolysin-induced Ca2+ release
(Fig. 5D), but not the second, slower, phase (Fig.
5E), nor the calcium entry across the plasma membrane. These
results demonstrate an activation of pertussis toxin-sensitive
G-proteins through aerolysin. The results obtained with pertussis toxin
(Fig. 5) and the PLC inhibitor (Fig. 4), however, also demonstrate that there is a second phase of Ca2+ release which does not
involve the G-protein/PLC/Ins(1,4,5)P3 pathway.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 5.
Aerolysin-induced Ca2+ release
from intracellular stores involves pertussis toxin-sensitive
G-proteins. HL-60 granulocytes were pretreated or not with
pertussis toxin (500 ng/ml) for 1 h at 37 °C, and subsequently
loaded with fura-2 as described under "Experimental Procedures."
Cells, suspended in Ca2+-free buffer, were then exposed to
10 (A), 100 (B), or 1000 (C) ng/ml of
aerolysin at the times indicated by an arrow. Near the end
of each experiment, Ca2+ (1 mM) followed by the
calcium ionophore ionomycin (2 µM) were added as
indicated. D, percentage of increase in fura-2 fluorescence
intensity at the first peak after toxin addition (i.e. peak
fluorescence minus basal fluorescence) was plotted as function of
aerolysin concentration for pertussis toxin treated and control cells.
E, percentage of increase in fura-2 fluorescence intensity
at 3 min after toxin addition (i.e. 3-min fluorescence minus
basal fluorescence) was plotted as function of aerolysin concentration
for pertussis toxin-treated and control cells.
|
|
Aerolysin Released Ca2+ from Thapsigargin and
Agonist-sensitive Ca2+ Stores--
A variety of
intracellular organelles are able to serve as intracellular
Ca2+ stores, the functionally most important of which is
thought to be the endoplasmic reticulum (ER). The ER can be subdivided
into agonist-sensitive and agonist-insensitive Ca2+ stores.
The ER Ca2+ stores are, in most cases, loaded through
Ca2+ pumps which belong to the group of the so-called
SERCAs (sarcoendoplasmic reticulum Ca2+-ATPases). All
sarcoendoplasmic reticulum Ca2+-ATPases known to date can
be inhibited by thapsigargin and are also the only known target of this
drug. In addition, this compound efficiently empties ER-type
Ca2+ stores in many cell types. We therefore investigated
the effect of depletion of ER-type Ca2+ stores through
thapsigargin on the aerolysin-induced Ca2+ signal. As shown
in Fig. 6A, thapsigargin led,
as expected, to a transient increase in [Ca2+]c
(Fig. 6A, see also Ref. 27). When aerolysin was added to
cells after thapsigargin treatment, both phases of the aerolysin-induced Ca2+ release were almost completely
abolished. Thus, the source of Ca2+ released by aerolysin
was the endoplasmic reticulum. Thapsigargin did, however, not inhibit
channel formation by aerolysin since Ca2+ entry and rapid
release of intracellular K+ were still observed.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
Aerolysin leads to the release of
Ca2+ from thapsigargin and agonist-sensitive stores.
[Ca2+]c was recorded in fura-2-loaded HL-60
granulocytes incubated in Ca2+-free buffer. A,
addition of the Ca2+-ATPase inhibitor thapsigargin (100 nM) or the equivalent volume of Me2SO
(first arrow) followed by the addition of aerolysin (100 ng/ml, second arrow). B, addition of the receptor
agonist fMLP (1 µM) or the equivalent volume of
Me2SO (first arrow) followed by the addition of
aerolysin (100 ng/ml, second arrow). C,
percentage of increase in fura-2 fluorescence intensity after 1 and 3 min after aerolysin addition in control (Me2SO treated),
thapsigargin, and fMLP-treated cells.
|
|
To investigate whether aerolysin induces Ca2+ release from
agonist-sensitive stores, we stimulated cells with the receptor agonist fMet-Leu-Phe (fMLP) in a Ca2+-free medium. Under these
conditions, Ca2+ is released from agonist-sensitive
Ca2+ stores and these stores remain depleted (23). The
predepletion of agonist-sensitive Ca2+ stores by fMLP
abolished the initial phase, but not the late phase of
aerolysin-induced Ca2+ release (Fig. 6, B and
C). Thus, the source of the initial phase of
aerolysin-induced Ca2+ release were agonist-sensitive
Ca2+ stores, while the source of the second phase also
included agonist-insensitive ER-type Ca2+ stores.
Aerolysin Induced Ca2+ Influx--
As already visible
from Figs. 3 and 4, the effect of aerolysin on
[Ca2+]c also included a major Ca2+
influx component. When Ca2+ was added to the cells (in a
Ca2+-free medium) after different times of incubation with
aerolysin, a time-dependent increase in the
Ca2+ permeability was observed, as witnessed by more rapid
increase in fura-2 fluorescence (Fig. 7,
A and B). These observations suggest that as more
aerolysin pores were formed, the kinetics of Ca2+ entry
were faster. We then analyzed the kinetics of entry of Mn2+, a Ca2+ surrogate commonly used to study
Ca2+ influx pathways. This divalent cation permeates in
small quantities through various Ca2+ channels; once inside
the cell, Mn2+ binds with high affinity (~100-fold higher
than Ca2+) to fura-2, thereby quenching the fura-2
fluorescence. As shown in Fig. 7B, the kinetics of
Mn2+ and Ca2+ influxes were very similar. In
order to rule out that the increase in divalent cation influx kinetics
were due to massive fura-2 release, we measured the amount of
extracellular fura-2 as described under "Experimental Procedures."
Less then 20% fura-2 was released into the medium after treatment of
HL-60 granulocytes with aerolysin (100 ng/ml) during 8 min in agreement
with the dye entry kinetics shown in Fig. 1D.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
Aerolysin-induced influx of divalent
cations. A, [Ca2+]c was recorded in
fura-2-loaded HL-60 granulocytes incubated in Ca2+-free
buffer. The fluorescence was monitored using an excitation wavelength
of 340 nm. After different times, Ca2+ was added to the
extracellular medium (1 mM). B, the percentage
of fluorescence increase that occurred within 10 s after addition
of Ca2+ to the extracellular medium was plotted as a
function of the time elapse between the addition of aerolysin and the
addition of Ca2+. Similarly the percentage of fluorescence
quenching that occurred within 1 min after addition of Mn2+
was plotted as a function of the time elapse between the addition of
aerolysin and the addition of Mn2+ (25 µM).
C, [Ca2+]c was recorded in
fura-2-loaded HL-60 granulocytes incubated in Ca2+-free
buffer. The fluorescence was monitored using an excitation wavelength
ex of 360 nm, which corresponds to the isosbestic point.
The first arrow indicates the addition of aerolysin (100 ng/ml) and the second the addition of Ni2+ (100 µM). D, [Ca2+]c was
recorded in fura-2-loaded HL-60 granulocytes incubated in
Ca2+-free buffer ( ex = 360 nm). Thapsigargin
(100 nM) was added or not at the first arrow and
Ni2+ (100 µM) at the second
arrow.
|
|
Given the fact that aerolysin led to a potassium efflux and plasma
membrane depolarization with kinetics similar to the ones observed for
divalent cation influx, it is likely that Ca2+ enters
through the pores formed by the toxin in the plasma membrane. It has
indeed been previously suggested that Ca2+ is able to
diffuse through the aerolysin channel (28). However, given the
aerolysin induced Ca2+ release from intracellular stores
(see above), the toxin could also activate endogenous store-operated
Ca2+ channels of granulocytes (23). Activation of
endogenous channels has been previously suggested for the
staphylococcal toxin leukocidin (29). To investigate this possibility,
we used the divalent cation Ni2+. We have previously shown
that this cation blocks store-operated Ca2+ influx (27). As
shown in Fig. 7C, addition of Ni2+ to
aerolysin-treated cells led to fura-2 quenching indicating that the
divalent cation had entered the cells. As a control, Fig. 7D
shows that Ni2+ addition to thapsigargin-treated cells had
no effect. Thus, in aerolysin-treated cells, divalent cations can enter
the cell through the pores formed by the toxin in the plasma membrane.
As suspected, neither the aerolysin-induced Ni2+ or
Ca2+ influx was blocked by pertussis toxin, indicating that
channel formation in the plasma membrane is G-protein independent (Fig. 5 and not shown).
Aerolysin-induced Ca2+ Release Occurs After a Lag
Time--
Fig. 8 shows, with high
resolution, the kinetics of aerolysin-induced Ca2+ release.
Strikingly, there was a substantial lag time between the addition of
aerolysin and the onset of Ca2+ release in contrast to what
is observed upon stimulation with the receptor agonist fMLP. Moreover,
the lag time was concentration dependent (Fig. 8C). Thus,
the marked lag time observed in response to aerolysin clearly
differentiated Ca2+ release in response to the toxin from
Ca2+ release in response to typical receptor agonists.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 8.
Kinetics of early changes in fura-2
fluorescence upon aerolysin or fMLP treatment. HL-60 granulocytes
were incubated in Ca2+ (A) or
Ca2+-free (B) buffer and the kinetics of
increase in fura-2 fluorescence upon addition of aerolysin or fMLP were
compared. C, the lag time between toxin addition and the
onset of the rise in fura-2 fluorescence was measured for various
aerolysin concentrations.
|
|
Effect of Digitonin, Staphylococcal -Toxin, and Streptolysin O
on Intracellular Ca2+--
To further understand the
mechanism of G-protein activation by aerolysin, we studied
Ca2+ signaling by other widely used cell permeabilizing
agents such as digitonin, staphylococcal -toxin, and streptolysin O. Digitonin is a plant lipid which, at low concentrations preferentially
binds to cholesterol and thereby leads to plasma membrane
permeabilization. As shown in Fig.
9A, addition of digitonin to
fura-2-loaded cells suspended in a Ca2+-free medium led to
a drop in fluorescence intensity. Upon subsequent addition of
Ca2+ to the extracellular medium, a rapid and large
increase in fluorescence was observed. These results indicate that
permeabilization was efficient but also that digitonin does not trigger
release of Ca2+ from intracellular stores. This observation
is not so surprising since digitonin has been widely used as a
permeabilizing agent in studies on the function of intracellular
Ca2+ stores in large variety of cell types, including
granulocytes (30). Thus, G-protein activation and Ca2+
release from intracellular stores are not simply due to cell permeabilization.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 9.
Effect of membrane permeabilizing agents on
the [Ca2+]c. HL-60 granulocytes were
incubated in Ca2+-free buffer. The changes in fura-2
fluorescence were monitored upon addition of digitonin (A,
12.5 µM), staphylococcal -toxin (B, 10 µg/ml), and streptolysin O (C, 50 ng/ml). Near the end of
each experiment, Ca2+ (1 mM) was added as
indicated.
|
|
Interestingly, however, we found that the two other pore-forming
bacterial toxins we have studied, staphylococcal -toxin and
streptolysin O, both induced Ca2+ release from
intracellular stores (Fig. 9B). Moreover, the
Ca2+ release triggered by both toxins was partly blocked by
pertussis toxin (Fig. 9C) as previously observed for
aerolysin. The observation that -toxin triggers Ca2+
release is difficult to reconcile with previous reports suggesting that
staphylococcal -toxin exclusively triggers Ca2+ influx
across the plasma membrane (31-33). Note, however, that Suttorp and
Habben (31) also did not detect a [Ca2+]c
increase in response to the Ca2+ ionophore ionomycin,
suggesting that the experimental conditions were not optimized with
respect to detection of Ca2+ release.
Pertussis Toxin-sensitive Chemotaxis in Response to Aerolysin,
-Toxin, and Streptolysin O--
To investigate whether
toxin-dependent G-protein activation activates cell
functions, we investigated the effect of aerolysin, -toxin, and
streptolysin O on chemotaxis of freshly prepared human blood
granulocytes (Fig. 10). Under control
conditions, less then 0.5% of the cells that had been added in the
cell reservoir of the chemotaxis chamber were recovered in the target
chamber. In contrast, when aerolysin, -toxin, or streptolysin O were
added to the target chamber, significant chemotactic activity was
observed. The chemotactic activity observed in response to the toxins
was of a similar magnitude as observed with classical chemoattractants, such as fMLP or platelet-activating factor (see also legend of Fig.
10). Importantly, chemotaxis in response to the toxins could be
completely blocked by preincubation of cells with pertussis toxin,
demonstrating that the activation of G-proteins by the toxins was
essential for the induction of chemotaxis.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 10.
Pertussis toxin-sensitive chemotaxis in
response to pore-forming toxins. Chemotaxis of freshly prepared
human blood granulocytes in response to aerolysin (panel A),
staphylococcal -toxin (panel B), or streptolysin O
(panel C) was assessed using a standard chemotaxis assay.
Cells were preincubated for 1 h without pertussis toxin
(black bars) or with pertussis toxin (gray bars).
For control conditions, toxins were omitted from the target chamber.
Data are expressed as % of cells recovered from the target chamber
(mean ± S.E.; n = 3). Using the same assay
system, chemotactic responses to standard chemoattractants were
1.5 ± 1.0% (1 nM fMLP) and 3.2 ± 2.3 (100 ng/ml platelet activating factor).
|
|
 |
DISCUSSION |
A. hydrophila may cause pyogenic infections, including
fecal leukocyte-positive diarrhea and purulent soft tissue infection. An important pathogenicity factor of this bacterium is the pore-forming toxin aerolysin. Thus, the question whether granulocytes are target cells for aerolysin is relevant. In this study, we demonstrate that
granulocytes are sensitive to aerolysin. We found that granulocytes are
more sensitive than promyelocytes suggesting that an up-regulation of
receptors may occur upon differentiation. We also show that granulocytes are able to proteolyticaly activate the protoxin thereby
allowing heptamerization of the toxin and channel formation as
witnessed by a loss of intracellular K+ and plasma membrane
depolarization. Finally we show that aerolysin induces
[Ca2+]c elevations. In agreement with a previous
study (34), we also demonstrate that aerolysin is chemotactic for human
granulocytes. However, our results not only define an aerolysin target
cell of potential pathophysiological importance. They also reveal novel and unexpected aspects of the mechanisms of cell activation by the
toxin, namely aerolysin-induced Ca2+ release from
intracellular stores and aerolysin-induced G-protein activation.
Aerolysin-induced Ca2+ Release from Intracellular
Stores--
A pore-forming toxin is expected to allow ion fluxes
across the plasma membrane. In accordance with this prediction, our
results demonstrate that aerolysin increases the plasma membrane
permeability for monovalent and divalent cations in granulocytes.
However, aerolysin-induced [Ca2+]c elevations
were more complex than anticipated. Experiments performed in the
absence of extracellular Ca2+ revealed that an early event
triggered by aerolysin was the release of Ca2+ from
intracellular stores. The Ca2+ release occurred in two
phases. The first phase of aerolysin-induced Ca2+ release
was rapid and transient. It could be inhibited by pertussis toxin as
well as the phospholipase C inhibitor U73122, indicating that it
involves the activation of a G-protein and PLC. This phase was also
abolished when agonist-sensitive Ca2+ stores were
predepleted by exposure of cells to the
Ins(1,4,5)P3-generating receptor agonist fMLP. Thus, the
source of the early phase of aerolysin-induced Ca2+ release
were most likely Ins(1,4,5)P3-sensitive endoplasmic
reticulum Ca2+ stores. The second phase of
aerolysin-induced Ca2+ release was more sustained, but of a
relatively low amplitude. It did not occur through a G-protein
phospholipase C pathway. This phase was completely abolished by
pretreatment of cells with thapsigargin, but only partially by
pretreatment with fMLP. Thus, the source of the second phase of
Ca2+ release most likely comprised not only
Ins(1,4,5)P3-sensitive, but also
Ins(1,4,5)P3-insensitive endoplasmic reticulum
Ca2+ stores. The mechanisms underlying the second release
phase have as yet to be determined. Generation of a yet unknown signal
at the plasma membrane might occur. Alternatively, a direct action of
aerolysin on the endoplasmic reticulum might be considered.
Aerolysin-induced G-protein Activation--
Our results clearly
suggest that aerolysin activates pertussis toxin-sensitive G-proteins
in granulocytes. This possibility has also been suggested by previous
reports on the block of aerolysin-induced granulocyte chemotaxis by
pertussis toxin (34). A most straightforward explanation for the
activation of G-proteins by aerolysin would be the following: the
aerolysin receptor on granulocytes is a G-protein-coupled receptor and
binding of aerolysin to this protein therefore induces G-protein
activation. However, for several reasons, we think that this
explanation is unlikely. First, the insertion-incompetent G202C/I445C
aerolysin mutant efficiently binds to the same cell surface receptors
as the wild type toxin, as evidenced by the almost complete block of
aerolysin-induced Ca2+ release by the preincubation with
the mutant. However, the mutant did not induce Ca2+
release. Second, the kinetics of increase in
[Ca2+]c were slower than those triggered by the
active form of the toxin, suggesting again that pore formation and not
binding is crucial for G-protein activation. Third, all proaerolysin
receptors identified so far are GPI-anchored proteins and not
transmembrane proteins. Finally, the existence of a lag time between
the addition of the toxin and the onset of Ca2+ release
argues against a direct binding to a G-coupled receptor. Indeed no lag
is observed upon addition of receptor agonists such as fMLP. Additional
evidence that aerolysin-induced G-protein activation is a consequence
of pore formation, rather than of receptor binding comes from the
observation that G-protein activation is a common theme observed in
response to pore formation by a variety of proteins and peptides.
Is G-protein Activation Commonly Associated with Pore
Formation?--
The ability of activating the Ins(1,4,5)P3
pathway is not unique to aerolysin, since both staphylococcal -toxin
and streptolysin O were found to trigger Ca2+ release (Fig.
9), and to induce chemotaxis (Fig. 10) in a
G-protein-dependent manner. Production of
Ins(1,4,5)P3 has also been shown to be triggered by two
other pore-forming proteins. Grimminger et al. (33, 35) have
shown that Escherichia coli hemolysin (HlyA) leads to
phosphoinositide hydrolysis and production of diacylglycerol but the
mechanism by which HlyA triggered a G-protein-dependent
pathway was not further analyzed (33, 35). The C5b-9 membrane attack
complex was also shown to trigger mobilization of calcium from
intracellular stores secondary to activation of phospholipase C and
production of Ins(1,4,5)P3 (36, 37). Therefore a number of
pore-forming proteins seem to be able to induce G-protein activation.
However, membrane permeabilization per se does not appear to
be sufficient since digitonin was unable to trigger Ca2+
release. The observation that a variety of pore-forming proteins lead
to G-protein activation also argues against the possibility that the
common mechanism resides at the receptor binding level. Indeed although
the receptors have not been identified for all these toxins, it is
clear that they do not share the same acceptor sites on cells.
Aerolysin has been shown to bind to GPI-anchored proteins cells
(11-14), and streptolysin O to cholesterol (for review, see Ref. 38).
Thus, rather than being on the level of toxin-receptor interaction, the
G-protein activation through bacterial toxins might be in relationship
to their insertion into the plasma membrane. Receptor-independent
G-protein activation through plasma membrane insertion of exogenously
added cationic amphiphilic neuropeptides and venom peptides has indeed
been described previously (39). Our observation that the onset of
Ca2+ release in response to the toxin was delayed with
respect to the onset of Ca2+ release in response to a
receptor agonist would be compatible with the present hypothesis.
 |
ACKNOWLEDGEMENTS |
We are thankful to J. T. Buckley for
providing us with the proaerolysin producing strain and the purified
proaerolysin mutant G202C/I445C, Beatrix Vecsey-Semjen for giving us
-toxin, and M. Kehoe for giving us purified streptolysin O. We are
very grateful to Nathalie Madore for going through all the trouble of
providing us with an anti-Thy-1 antibody and are thankful to Roger
Morris for giving us the antibody. We thank Eduardo Martinez for human T lymphocytes and Hai-Tao He for mouse T lymphocytes.
 |
FOOTNOTES |
*
This work was supported by Swiss National Science Foundation
Grants 3100-04 5891.95/1 (to K-H. K.) and 3100-049195.96/1 (to G. v. d. G).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel./Fax:
41-022-702-6414; E-mail: Gisou.vandergoot{at}biochem.unige.ch.
1
The abbreviations used are: GPI,
glycosylphosphatidylinositol; PAGE, polyacrylamide gel electrophoresis;
PLC, phospholipase C; Ins(1,4,5)P3, inositol
1,4,5-trisphosphate; Me2SO, dimethyl sulfoxide; ER,
endoplasmic reticulum; fMLP, fMet-Leu-Phe; PBFI, K+-binding
benzofuran isophthalate.
2
. Abrami, M. Fivaz, and F. G. van der
Goot, unpublished data.
 |
REFERENCES |
-
Donta, S. T.,
and Haddow, A. P.
(1978)
Infect. Immun.
21,
989-993[Abstract/Free Full Text]
-
Daily, O. P.,
Joseph, S. W.,
Coolbaugh, J. C.,
Walker, R. I.,
Merrell, B. R.,
Rollins, D. M.,
Seidler, R. J.,
Colwell, R. R.,
and Lissner, C. R.
(1981)
J. Clin. Microbiol.
13,
769-777[Abstract/Free Full Text]
-
Kaper, J. B.,
Lockman, H.,
and Colwell, R. R.
(1981)
J. Appl. Bacteriol.
50,
359-377[Medline]
[Order article via Infotrieve]
-
Janda, J. M.,
Bottone, D. J.,
Sinner, C. V.,
and Calcaterra, D.
(1984)
J. Clin. Microbiol.
17,
588-591
-
Chakraborty, T.,
Hihle, B.,
Berghauer, H.,
and Goebel, W.
(1987)
Infect. Immun.
55,
2274-2280[Abstract/Free Full Text]
-
Howard, S. P.,
and Buckley, J. T.
(1982)
Biochemistry
21,
1662-1667[CrossRef][Medline]
[Order article via Infotrieve]
-
van der Goot, F.,
Ausio, J.,
Wong, K.,
Pattus, F.,
and Buckley, J.
(1993)
J. Biol. Chem.
268,
18272-18279[Abstract/Free Full Text]
-
Howard, S. P.,
and Buckley, J. T.
(1985)
J. Bacteriol.
163,
336-340[Abstract/Free Full Text]
-
van der Goot, F. G.,
Lakey, J. H.,
Pattus, F.,
Kay, C. M.,
Sorokine, O.,
Van Dorsselaer, A.,
and Buckley, T.
(1992)
Biochemistry
31,
8566-8570[CrossRef][Medline]
[Order article via Infotrieve]
-
Gruber, H. J.,
Wilmsen, H. U.,
Cowell, S.,
Schindler, H.,
and Buckley, J. T.
(1994)
Mol. Microbiol.
14,
1093-1101[CrossRef][Medline]
[Order article via Infotrieve]
-
Nelson, K. L.,
Raja, S. M.,
and Buckley, J. T.
(1997)
J. Biol. Chem.
272,
12170-12174[Abstract/Free Full Text]
-
Cowell, S.,
Aschauer, W.,
Gruber, H. J.,
Nelson, K. L.,
and Buckley, J. T.
(1997)
Mol. Microbiol.
25,
343-350[CrossRef][Medline]
[Order article via Infotrieve]
-
Diep, D. B.,
Nelson, K. L.,
Raja, S. M.,
Pleshak, E. N.,
and Buckley, J. T.
(1998)
J. Biol. Chem.
273,
2355-2360[Abstract/Free Full Text]
-
Abrami, L.,
Fivaz, M.,
Buckley, J. T.,
Parton, R. G.,
and van der Goot, F. G.
(1998)
J. Cell. Biol.
140,
525-540[Abstract/Free Full Text]
-
Garland, W. J.,
and Buckley, J. T.
(1988)
Infect. Immun.
56,
1249-1253[Abstract/Free Full Text]
-
Wilmsen, H. U.,
Pattus, F.,
and Buckley, J. T.
(1990)
J. Membr. Biol.
115,
71-81[CrossRef][Medline]
[Order article via Infotrieve]
-
Wilmsen, H. U.,
Leonard, K. R.,
Tichelaar, W.,
Buckley, J. T.,
and Pattus, F.
(1992)
EMBO J.
11,
2457-2463[Medline]
[Order article via Infotrieve]
-
Moniatte, M.,
van der Goot, F. G.,
Buckley, J. T.,
Pattus, F.,
and Van Dorsselaer, A.
(1996)
FEBS Lett.
384,
269-272[CrossRef][Medline]
[Order article via Infotrieve]
-
Buckley, J. T.
(1990)
Biochem. Cell Biol.
68,
221-224[Medline]
[Order article via Infotrieve]
-
van der Goot, F. G.,
Hardie, K. R.,
Parker, M. W.,
and Buckley, J. T.
(1994)
J. Biol. Chem.
269,
30496-30501[Abstract/Free Full Text]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
-
Kasner, S. E.,
and Ganz, M. B.
(1992)
Am. J. Physiol.
262,
F462-F467[Abstract/Free Full Text]
-
Demaurex, N.,
Monod, A.,
Lew, D.,
and Krause, K.-H.
(1994)
Biochem. J.
297,
595-601
-
Schlossman, S. F.,
Boumsel, L.,
Gilks, W.,
Harlan, J. M.,
Kishimoto, T.,
Morimoto, C.,
Ritz, J.,
Shaw, S.,
Silverstein, R.,
Springer, T.,
Tedder, T. F.,
and Todd, R. F.
(1995)
Leukcocyte Typing V. White Cell Differentiation Antigens, p. 154, Oxford University Press, Oxford
-
Papini, E.,
Sandona, D.,
Rappuoli, R.,
and Montecucco, C.
(1988)
EMBO J.
7,
3353-3359[Medline]
[Order article via Infotrieve]
-
Krause, K. H.,
Schlegel, W.,
Wollheim, C. B.,
Andersson, T.,
Waldvogel, F. A.,
and Lew, P. D.
(1985)
J. Clin. Invest.
76,
1348-1354
-
Demaurex, N.,
Lew, D. P.,
and Krause, K. H.
(1992)
J. Biol. Chem.
267,
2318-2324[Abstract/Free Full Text]
-
Tschödrich-Rotter, M.,
Kubitscheck, U.,
Ugochukwu, G.,
Buckley, J.,
and Peters, R.
(1996)
Biophys. J.
70,
723-732[Medline]
[Order article via Infotrieve]
-
Staali, L., Monteil, H., and Colin, D. A. (1998) in
Bacterial Protein Toxins (Fehrenbach, F. J., ed) Vol.,
Gustave Fisher Verlag, in press
-
Prentki, M.,
Wollheim, C. B.,
and Lew, P. D.
(1984)
J. Biol. Chem.
259,
13777-13782[Abstract/Free Full Text]
-
Suttorp, N.,
and Habben, E.
(1988)
Infect. Immun.
56,
2228-2234[Abstract/Free Full Text]
-
Fink, D.,
Contreras, M. L.,
Lelkes, P. I.,
and Lazarovici, P.
(1989)
Cell. Signalling
1,
387-393[CrossRef][Medline]
[Order article via Infotrieve]
-
Grimminger, F.,
Rose, F.,
Sibelius, U.,
Meinhardt, M.,
Potzsch, B.,
Spriestersbach, R.,
Bhakdi, S.,
Suttorp, N.,
and Seeger, W.
(1997)
J. Immunol.
159,
1909-1916[Abstract]
-
Jin, G.-F.,
Chopra, A. K.,
and Houston, C. W.
(1992)
FEMS Microbiol. Lett.
98,
285-290[CrossRef]
-
Grimminger, F.,
Sibelius, U.,
Bhakdi, S.,
Suttorp, N.,
and Seeger, W.
(1991)
J. Clin. Invest.
88,
1531-1539
-
Morgan, B. P.,
and Campbell, A. K.
(1985)
Biochem. J.
231,
205-208[Medline]
[Order article via Infotrieve]
-
Cybulsky, A. V.,
Salant, D. J.,
Quigg, R. J.,
Badalamenti, J.,
and Bonventre, J. V.
(1989)
Am. J. Physiol.
257,
F826-F836[Abstract/Free Full Text]
-
Bhakdi, S.,
Bayley, H.,
Valeva, A.,
Walev, I.,
Walker, B.,
Kehoe, M.,
and Palmer, M.
(1996)
Arch. Microbiol.
165,
73-79[CrossRef][Medline]
[Order article via Infotrieve]
-
Mousli, M.,
Bueb, J. L.,
Bronner, C.,
Rouot, B.,
and Landry, Y.
(1990)
Trends Pharmacol. Sci.
11,
358-362[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Katayama, Y. Kusaka, H. Yokota, T. Akao, M. Kojima, O. Nakamura, E. Mekada, and E. Mizuki
Parasporin-1, a Novel Cytotoxic Protein from Bacillus thuringiensis, Induces Ca2+ Influx and a Sustained Elevation of the Cytoplasmic Ca2+ Concentration in Toxin-sensitive Cells
J. Biol. Chem.,
March 9, 2007;
282(10):
7742 - 7752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Iliev, J. R. Djannatian, R. Nau, T. J. Mitchell, and F. S. Wouters
Cholesterol-dependent actin remodeling via RhoA and Rac1 activation by the Streptococcus pneumoniae toxin pneumolysin
PNAS,
February 20, 2007;
104(8):
2897 - 2902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Rotblat, O. Yizhar, R. Haklai, U. Ashery, and Y. Kloog
Ras and Its Signals Diffuse through the Cell on Randomly Moving Nanoparticles
Cancer Res.,
February 15, 2006;
66(4):
1974 - 1981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Epple, J. Mankertz, R. Ignatius, O. Liesenfeld, M. Fromm, M. Zeitz, T. Chakraborty, and J. D. Schulzke
Aeromonas hydrophila Beta-Hemolysin Induces Active Chloride Secretion in Colon Epithelial Cells (HT-29/B6)
Infect. Immun.,
August 1, 2004;
72(8):
4848 - 4858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Boston, G. C. Frech, E. Chacon-Cruz, E. S. Buescher, and D. G. Oelberg
Surfactant Releases Internal Calcium Stores in Neutrophils by G Protein-Activated Pathway
Experimental Biology and Medicine,
January 1, 2004;
229(1):
99 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Marlink, K. D. Bacon, B. C. Sheppard, H. Ashktorab, D. T. Smoot, T. L. Cover, C. W. Deveney, and M. J. Rutten
Effects of Helicobacter pylori on intracellular Ca2+ signaling in normal human gastric mucous epithelial cells
Am J Physiol Gastrointest Liver Physiol,
June 9, 2003;
285(1):
G163 - G176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Abrami, M. Fivaz, P.-E. Glauser, N. Sugimoto, C. Zurzolo, and F. G. van der Goot
Sensitivity of Polarized Epithelial Cells to the Pore-Forming Toxin Aerolysin
Infect. Immun.,
February 1, 2003;
71(2):
739 - 746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ribeiro, M. Vignes, and M. Brehelin
Xenorhabdus nematophila (Enterobacteriacea) Secretes a Cation-selective Calcium-independent Porin Which Causes Vacuolation of the Rough Endoplasmic Reticulum and Cell Lysis
J. Biol. Chem.,
January 24, 2003;
278(5):
3030 - 3039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hetz, M. R. Bono, L. F. Barros, and R. Lagos
Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines
PNAS,
March 5, 2002;
99(5):
2696 - 2701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Macey, R. A. Whiley, L. Miller, and H. Nagamune
Effect on Polymorphonuclear Cell Function of a Human-Specific Cytotoxin, Intermedilysin, Expressed by Streptococcus intermedius
Infect. Immun.,
October 1, 2001;
69(10):
6102 - 6109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Prou, W.-J. Gu, S. Le Crom, J.-D. Vincent, J. Salamero, and P. Vernier
Intracellular retention of the two isoforms of the D2 dopamine receptor promotes endoplasmic reticulum disruption
J. Cell Sci.,
January 10, 2001;
114(19):
3517 - 3527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Chopra, X.-J. Xu, D. Ribardo, M. Gonzalez, K. Kuhl, J. W. Peterson, and C. W. Houston
The Cytotoxic Enterotoxin of Aeromonas hydrophila Induces Proinflammatory Cytokine Production and Activates Arachidonic Acid Metabolism in Macrophages
Infect. Immun.,
May 1, 2000;
68(5):
2808 - 2818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fivaz, M.-C. Velluz, and F. G. van der Goot
Dimer Dissociation of the Pore-forming Toxin Aerolysin Precedes Receptor Binding
J. Biol. Chem.,
December 31, 1999;
274(53):
37705 - 37708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Abrami and F. G. van der Goot
Plasma Membrane Microdomains Act as Concentration Platforms to Facilitate Intoxication by Aerolysin
J. Cell Biol.,
October 4, 1999;
147(1):
175 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|